Member Info for Toukankahmoon

Nigh

I made it quite clear in my post why I challenge baseless ramping on here. But like the rampers you choose to ignore that part of my post. There are folks on here that have fallen in love with this share - I understand that, the science is beguiling. But they aren’t well researched in that they only look at the science and have little regard for anything else including what is happening with competitive treatments. A lot of these “investors “ are well under water and have to keep their spirits up by posting delusional ramps. Often encouraging people to buy because we will never get a chance at these prices again. If you fell for this then I am sorry and I have failed. But I will continue to challenge this nonsense.

No one that posts on here is paid. People who write articles or have columns in investment magazines may make a living out of promoting some shares.

Finally most IPs don’t have the wherewithal to run shorts.

So please encourage the tribal nature that ruins this BB

DG

I usually agree with most of your posts but not the last bit of this one.

You are forgetting the unwritten rules of this BB that only rampers can post anything based on just a gut feeling.

Flippin

I think that’s we all hope that. But it isn’t a very good strategy for investing is it?

Shame you haven’t the patience to wait for the raise then you would likely get many more shares for the same money. IMHO of course

Timmie

It’s the Pom Pom girls who always working hard. And they have to keep their spirits up given where we are.

Yep but as IceCool says, by the time we get an RNS it’s too late!!!!

Yeh Myles and his acolytes have researched Avacta more thoroughly than AIM, the FDA, Big Pharma and the institutional investors and they know far more than anyone including CC. No idea where they are getting the data from? Trouble is they are just looking at the science in isolation. Even worse they aren’t looking at the potential competition. And they insist that they are seasoned investors 🤡🤡🤡

DG

I did buy in the last one in order offset some dilution. That was the last time I bought or sold Avacta and no other time in well over 2 years. So I do have funds to buy this time. Timmy said two years ago it would be 20p and if so then yes I would buy because the funding would take us to the point where CC expects P1b to be done and dusted.

Aaah. I forgot it was bank holiday. Could get the raise RNS at 5pm tomorrow

IceCool

Silence has never been golden with is share.

Why should it be any different this time.

Best we can hope for is great discount for current holders

The issue isn’t CC or the BoD.

The problem is that the convincing clinical trial results aren’t there yet. Simples

My guess is RNS 7am Thursday announcing terms of immediate raise. There better be good preferential price for current investors.

CC loves a Thursday RNS

. . . and **** stirrer extraordinaire miraculously appears to fan the flames

More baseless delusional ramping by the unexpectedly exceptional researched. Ah bless they have to keep their spirits and hopes up somehow.

I’m not sat out. If anything I’ve got too much of my portfolio in this.

How many times over the last two years have you said words to the effect of :

“But don’t act surprised when that 7am red dot drops and you’re chasing at 5x + the price because you couldn’t see past the noise. When AIM finally wakes up and reacts, which it will imo”

OR

“You’ll never get another chance to buy at this price”

. . . and yet the SP has just dropped lower and lower.

If I had believed you like a number of others have on this BB, I would’ve lost thousands. Instead I am just sat on that money waiting to to do very well on a fund raise at 25p

TheGord

What CC said

Opti

Agree with sentiment of your post and most of what you said except NDA.

Where is he?

After ramping this share and bad mouthing me for calling him out, has he given up, swallowed his loss and sold up ?

No stamina in these youngsters. ABDX will come good in the long term I’m sure.

Wyn is right to be concerned about competing treatments. Precision is a superb platform but focusing on the right warheads to combine with is a nightmare. Chemotherapy drugs are not the right warheads long term. Chemotherapy doesn’t cure cancer. In a lot of cases the result of treatment is a period of remission which of course does give patients a longer happier life but it is not a cure.

Gene therapy and other competitors offer hope of permanent cure or preventing cancer in the first place. That is why BP are prepared to invest billions.

TheGord

. . . they aren’t listening. They are still seeing this as a 20 bagger. They have no regard for the fact that R&D for the pipeline “beasts” is going to swallow any profit from AVA6000 and probably AVA6103 for the next 10 years or more. And this all assumes that we don’t get taken over for £1 per share.